Engine Capital Management’s Trinity Biotech TRIB Stock Holding History

Engine Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-29	Closed	-$12K	–	56
2019 Q1	$12K	Hold	29	–	–	0.01%	48
2018 Q4	$10K	Hold	29	–	–	0.01%	48
2018 Q3	$17K	Hold	29	–	–	0.02%	48
2018 Q2	$21K	Hold	29	–	–	0.01%	52
2018 Q1	$22K	Hold	29	–	–	0.01%	45
2017 Q4	$22K	Buy	+29	New	+$22.4K	0.01%	35

Other funds holding TRIB

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Engine Capital Management's TRIB Position: Q2 2019 in Review

Engine Capital Management sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 29 shares — an estimated $12K sold.

Engine Capital Management first reported a position in TRIB in Q4 2017 and held it in 6 quarters. The position peaked at $22K in Q1 2018. 34 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.

Engine Capital Management reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
Engine Capital Management sold 29 Trinity Biotech shares in Q2 2019, an estimated $12K.
Engine Capital Management first reported a position in Trinity Biotech in Q4 2017 and held it in 6 quarters.
Engine Capital Management's Trinity Biotech position peaked at $22K in Q1 2018.
34 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.

Based on Engine Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.